Bank of America
ANIP icon

Bank of America’s ANI Pharmaceuticals ANIP Stock Holding History

Bank of America’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Buy
150,532
+104,828
+229% +$8.18M ﹤0.01% 2829
2025
Q4 		$3.61M Sell
45,704
-85,028
-65% -$7.36M ﹤0.01% 3635
2025
Q3 		$12M Sell
130,732
-54,733
-30% -$4.46M ﹤0.01% 3122
2025
Q2 		$12.1M Buy
185,465
+44,916
+32% +$2.92M ﹤0.01% 3052
2025
Q1 		$9.41M Buy
140,549
+45,389
+48% +$2.71M ﹤0.01% 3199
2024
Q4 		$5.26M Buy
95,160
+29,584
+45% +$1.7M ﹤0.01% 3546
2024
Q3 		$3.91M Buy
65,576
+39,912
+156% +$2.43M ﹤0.01% 3971
2024
Q2 		$1.63M Buy
25,664
+13,325
+108% +$865K ﹤0.01% 4574
2024
Q1 		$853K Sell
12,339
-13,243
-52% -$799K ﹤0.01% 5024
2023
Q4 		$1.41M Buy
25,582
+3,102
+14% +$171K ﹤0.01% 4714
2023
Q3 		$1.31M Buy
22,480
+2,427
+12% +$140K ﹤0.01% 4616
2023
Q2 		$1.08M Sell
20,053
-5,180
-21% -$230K ﹤0.01% 4724
2023
Q1 		$1M Sell
25,233
-3
-0% -$127 ﹤0.01% 4896
2022
Q4 		$1.02M Buy
25,236
+9,245
+58% +$347K ﹤0.01% 4836
2022
Q3 		$514K Sell
15,991
-1,845
-10% -$63.2K ﹤0.01% 5374
2022
Q2 		$529K Buy
17,836
+5,638
+46% +$163K ﹤0.01% 5404
2022
Q1 		$343K Buy
12,198
+2,465
+25% +$91.9K ﹤0.01% 6084
2021
Q4 		$448K Sell
9,733
-4,768
-33% -$205K ﹤0.01% 5972
2021
Q3 		$476K Buy
14,501
+6,788
+88% +$211K ﹤0.01% 5683
2021
Q2 		$270K Sell
7,713
-6,011
-44% -$204K ﹤0.01% 5864
2021
Q1 		$496K Buy
13,724
+8,634
+170% +$270K ﹤0.01% 5372
2020
Q4 		$147K Sell
5,090
-10,639
-68% -$305K ﹤0.01% 5782
2020
Q3 		$444K Buy
15,729
+7,178
+84% +$214K ﹤0.01% 4801
2020
Q2 		$276K Buy
8,551
+223
+3% +$8K ﹤0.01% 5027
2020
Q1 		$339K Buy
8,328
+1,955
+31% +$104K ﹤0.01% 4780
2019
Q4 		$393K Sell
6,373
-10,711
-63% -$710K ﹤0.01% 5180
2019
Q3 		$1.25M Buy
17,084
+8,462
+98% +$633K ﹤0.01% 4400
2019
Q2 		$709K Sell
8,622
-4,387
-34% -$312K ﹤0.01% 4825
2019
Q1 		$918K Sell
13,009
-21,496
-62% -$1.26M ﹤0.01% 4579
2018
Q4 		$1.55M Sell
34,505
-3,850
-10% -$202K ﹤0.01% 4049
2018
Q3 		$2.17M Buy
38,355
+32,373
+541% +$1.98M ﹤0.01% 3911
2018
Q2 		$400K Sell
5,982
-2,851
-32% -$178K ﹤0.01% 5022
2018
Q1 		$514K Sell
8,833
-465
-5% -$29.5K ﹤0.01% 4794
2017
Q4 		$598K Sell
9,298
-15,089
-62% -$939K ﹤0.01% 4830
2017
Q3 		$1.28M Sell
24,387
-56,198
-70% -$2.68M ﹤0.01% 4335
2017
Q2 		$3.77M Sell
80,585
-116,639
-59% -$5.63M ﹤0.01% 3296
2017
Q1 		$9.76M Buy
197,224
+40,111
+26% +$2.25M ﹤0.01% 2399
2016
Q4 		$9.53M Buy
157,113
+67,406
+75% +$4.12M ﹤0.01% 2364
2016
Q3 		$5.95M Buy
89,707
+6,955
+8% +$435K ﹤0.01% 2672
2016
Q2 		$4.62M Buy
82,752
+7,754
+10% +$377K ﹤0.01% 2864
2016
Q1 		$2.52M Buy
74,998
+9,217
+14% +$313K ﹤0.01% 3370
2015
Q4 		$2.97M Sell
65,781
-10,352
-14% -$446K ﹤0.01% 3449
2015
Q3 		$3.01M Buy
76,133
+62,604
+463% +$3.56M ﹤0.01% 3383
2015
Q2 		$840K Buy
13,529
+7,946
+142% +$473K ﹤0.01% 4250
2015
Q1 		$350K Sell
5,583
-72
-1% -$4.38K ﹤0.01% 4558
2014
Q4 		$319K Buy
5,655
+4,457
+372% +$197K ﹤0.01% 4986
2014
Q3 		$34K Sell
1,198
-4,300
-78% -$129K ﹤0.01% 6760
2014
Q2 		$189K Sell
5,498
-527
-9% -$16.5K ﹤0.01% 5613
2014
Q1 		$188K Buy
6,025
+1,205
+25% +$32K ﹤0.01% 5488
2013
Q4 		$97K Buy
4,820
+131
+3% +$1.7K ﹤0.01% 6148
2013
Q3 		$46K Buy
4,689
+47
+1% +$339 ﹤0.01% 6472
2013
Q2 		$28K Buy
+4,642
New +$32.5K ﹤0.01% 6828

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America's ANIP Position: Q1 2026 in Review

Bank of America increased its ANI Pharmaceuticals (ANIP) stake by 229% in Q1 2026, buying an estimated $8.18M and bringing the position to 150,532 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

Bank of America first reported a position in ANIP in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.1M in Q2 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Bank of America held 150,532 shares of ANI Pharmaceuticals worth $11.6M as of Q1 2026.
  • Bank of America bought 104,828 ANI Pharmaceuticals shares in Q1 2026, an estimated $8.18M.
  • ANI Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2829 holding.
  • Bank of America first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's ANI Pharmaceuticals position peaked at $12.1M in Q2 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.